Loss of p15INK4b function and CDKN2B mutations has been described in several types of tumors [57,61–63] confirming that the inactivation of p15INK4b significantly contributes to the transformation of normal cells into cancer cells. The gene discussed is CDKN2B; the disease is cancer.